Lurasidone
- Active ingredient / generic name
- lurasidone
- ATC code
- N05AE05
Source-based interaction record
Lurasidone + Orphenadrine
Lurasidone + Orphenadrine: published drug interaction record, medicine facts and reference links. Generic / active ingredient: lurasidone + orphenadrine (citrate; oral muscle-relaxant formulation).
Free preview
Essential record information
Free record overview for Lurasidone + Orphenadrine. Review the medicine identities and available reference links below; detailed interaction information is in the access section.
Orphenadrine
- Active ingredient / generic name
- orphenadrine (citrate; oral muscle-relaxant formulation)
- ATC code
- M03BC01
- Record type
- Published interaction record
- Source record version
- Australian Norflex oral modified-release tablets PI 06.11.2025; government Medicine Finder
Record sources
Source checked:
A source check is not an independent clinical review.
Examples selected from real records
Selected free interaction examples
These examples concern other medicine pairs involving the medicines above. They do not assess the main pair on this page.
Published related records: 282. The selection below does not represent the complete list.
No eligible low-level example is currently selected for this section. This does not mean that other interactions do not exist.
Examples selected from real records
Other related records
The identity and source of these published related records are shown below. Clinical details are displayed according to your access to each record.
Details require access
Orphenadrine + Oxycodone
The interaction assessment and details for this pair are in that page’s access section.
dailymed.nlm.nih.gov (opens in a new tab)Source checked:
Details and access Details require access
Morphine + Orphenadrine
The interaction assessment and details for this pair are in that page’s access section.
dailymed.nlm.nih.gov (opens in a new tab)Source checked:
Details and access Details require access
Methadone + Orphenadrine
The interaction assessment and details for this pair are in that page’s access section.
dailymed.nlm.nih.gov (opens in a new tab)Source checked:
Details and access Important information and detailed context
Unlock important interaction details
The basic information is available above. Details such as explanations of moderate or severe interaction records, mechanisms and clinical context are available through paid access to the relevant record or your membership allowance.
The related record group also includes interactions classified as moderate or severe. Each record’s access right applies to its own details.
- Interaction level and explanation
- Interaction mechanism
- Clinical context and precautions
Already have an account? Sign in
Monthly memberships renew automatically; there is no trial period. Taxes and the final total appear in checkout.
A verified account is required. Turkish and English versions of the same resource share one access right.
This information is not personal treatment advice. Discuss treatment decisions with your doctor or pharmacist.